About Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF 1D

XB31 top holdings are JPMorgan Chase & Co. 4.457% 13-NOV-2031 and Thermo Fisher Scientific (Finance I) BV 0.8% 18-OCT-2030, occupying 1.01% and 0.80% of the portfolio correspondingly.

XB31 last dividends amounted to 0.13 EUR. The quarter before, the issuer paid 0.13 EUR in dividends,

XB31 assets under management is ‪142.45 M‬ EUR. It's risen 6.92% over the last month.

XB31 fund flows account for ‪79.18 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

Yes, XB31 pays dividends to its holders with the dividend yield of 1.74%. The last dividend (Jun 5, 2025) amounted to 0.13 EUR. The dividends are paid quarterly.

XB31 expense ratio is 0.12% meaning you'd have to pay 0.12% of your investment to help manage the fund.

XB31 follows the Bloomberg MSCI Euro Corporate September 2031 SRI Index - EUR - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

XB31 invests in bonds.

XB31 price has risen by 0.15% over the last month, and its yearly performance shows a 4.56% increase. See more dynamics on XB31 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 1.07% over the last month, showed a 2.35% increase in three-month performance and has increased by 6.11% in a year.